Evidence map›Paper›PMID 35737860›Full record

ArticleJournal of managed care & specialty pharmacy2022

Economic burden of interstitial lung disease in a commercially insured population with Sjögren syndrome in the United States.

Tsung-Ying Lee, Julia F Slejko, Bernard Bright Davies-Teye, Eberechukwu Onukwugha

Open access · greenAbstract read
In one paragraph

Article in Journal of managed care & specialty pharmacy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Economic burden and cost drivers of interstitial lung disease: a systematic review.The European journal of health economics : HEPAC : health economics in prevention and care · 2026
    Pooled it
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Tsung-Ying LeeDepartment of Pharmaceutical Health Services Research, School of Pharmacy, University of Maryland, Baltimore.
Julia F SlejkoDepartment of Pharmaceutical Health Services Research, School of Pharmacy, University of Maryland, Baltimore.
Bernard Bright Davies-TeyeDepartment of Pharmaceutical Health Services Research, School of Pharmacy, University of Maryland, Baltimore.
Eberechukwu OnukwughaDepartment of Pharmaceutical Health Services Research, School of Pharmacy, University of Maryland, Baltimore.
University of Maryland, Baltimore · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Lung Diseases, InterstitialSjogren's SyndromeCost of IllnessFinancial StressHealth Care CostsHumansQuality of LifeRetrospective StudiesUnited States

Identifiers

PMID35737860
PMCPMC10372984
OpenAlexW4283453445

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.